MT2A and cancer: MT2A and TRIM31 which were engaged in IFN-γ signaling, CDC6, SGK1 and PTP4A1 genes, presented a homogeneous expression pattern in both test and Validation datasets, although our results were contradictory to other studies in different cancers.